| Cat.No. | Name | Information |
|---|---|---|
| M2106 | Azilsartan | Azilsartan (TAK-536) is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM. |
| M10146 | TRV-120027 TFA | TRV-120027 (also known as TRV027) is an angiotensin II receptor type 1 (AT1R) antagonist and engages ß-arrestins while blocking G-protein signaling. |
| M3507 | Valsartan | Valsartan is an angiotensin II receptor antagonist with IC50 of ranging from 39.5 to 116 μM. |
| M5731 | LCZ696 | LCZ696, consisting of Valsartan and Sacubitril in a 1:1 molar ratio, is a first-in-class dual-action angiotensin receptor-neprilysin inhibitor (ARNi,angiotensin receptor-neprilysin inhibitor) for the study of hypertension and heart failure. |
| M53938 | H-Val-Pro-Pro-OH | H-Val-Pro-Pro-OH, a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM. |
| M53844 | H-Val-Pro-Pro-OH TFA | H-Val-Pro-Pro-OH (TFA), a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM. |
| M53273 | C-Type Natriuretic Peptide (1-53), human | C-Type Natriuretic Peptide (1-53), human is the 1-53 fragment of C-Type Natriuretic Peptide. |
| M53272 | Brain Natriuretic Peptide (1-32), rat | Brain Natriuretic Peptide (1-32), rat (BNP (1-32), rat) is a 32 amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells (cardiomyocytes). |
| M53271 | Angiotensin II (1-4), human | Angiotensin II (1-4), human is an endogenous peptide produced from AT I by angiotensin-converting-enzyme (ACE). |
| M53270 | [Sar1, Ile8]-Angiotensin II | [Sar1, Ile8]-Angiotensin II is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels. |
| M53269 | [Tyr(P)4] Angiotensin II | [Tyr(P)4] Angiotensin II is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels. |
| M53268 | Angiotensinogen (1-13) (human) | Angiotensinogen (1-13) (human) is a fragment of the renin substrate angiotensinogen. |
| M53267 | Angiotensin II (3-8), human | Angiotensin II (3-8), human is a less effective agonist at the angiotensin AT1 receptor. |
| M53266 | Angiotensin II antipeptide | Angiotensin II antipeptide, a peptide, is an inverse agonist of AR1 receptor. |
| M53265 | Saralasin acetate hydrate | Saralasin ([Sar1,Ala8] Angiotensin II) acetate hydrate is an octapeptide analog of angiotensin II. |
| M53264 | Angiotensin I/II (1-5) | Angiotensin I/II 1-5 is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. |
| M53263 | Angiotensin I/II (1-6) | Angiotensin I/II 1-6 contains the amino acids 1-6 and is converted from Angiotensin I/II peptide. |
| M53262 | Angiotensin amide | Angiotensin amide ((Asn1,Val5)-Angiotensin II) is a potent vasoconstrictor. |
| M53261 | Saralasin | Saralasin ([Sar1,Ala8] Angiotensin II) is an octapeptide analog of angiotensin II. |
| M50177 | VP01 | VP01 is an orally active, low molecular weight angiotensin II-2 type 2 receptor (AT2R) agonist for studies related to idiopathic pulmonary fibrosis (IPF). |
| M49413 | C-106 | C-106 is an angiotensin II-2 type 2 receptor (AT2R) agonist that may be used in studies related to idiopathic pulmonary fibrosis (IPF). |
| M49412 | MOR-107 | MOR-107 is an angiotensin II-2 type 2 receptor (AT2R) agonist that may be used in studies related to idiopathic pulmonary fibrosis (IPF). |
| M41782 | CNP-38 | CNP-38 is a C-type natriuretic peptide. |
| M41781 | Allisartan isoproxil | Allisartan isoproxil (ALS-3) is an orally potent, selective, non-peptide inhibitor of Angiotensin II Type 1. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
